128 related articles for article (PubMed ID: 26517644)
1. Concordance of HER2 expression in paired primary and metastatic sites of gastric and gastro-oesophageal junction cancers.
Wong DD; Kumarasinghe MP; Platten MA; de Boer WB
Pathology; 2015 Dec; 47(7):641-6. PubMed ID: 26517644
[TBL] [Abstract][Full Text] [Related]
2. HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program.
Kumarasinghe MP; Morey A; Bilous M; Farshid G; Francis G; Lampe G; McCue G; Von Neumann-Cosel V; Fox SB
Pathology; 2017 Oct; 49(6):575-581. PubMed ID: 28823752
[TBL] [Abstract][Full Text] [Related]
3. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
[TBL] [Abstract][Full Text] [Related]
4. HER2 status in gastric/gastro-oesophageal junctional cancers: should determination of gene amplification by SISH use HER2 copy number or HER2: CEP17 ratio?
Kumarasinghe MP; de Boer WB; Khor TS; Ooi EM; Jene N; Jayasinghe S; Fox SB
Pathology; 2014 Apr; 46(3):184-7. PubMed ID: 24614718
[TBL] [Abstract][Full Text] [Related]
5. Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
Bozzetti C; Negri FV; Lagrasta CA; Crafa P; Bassano C; Tamagnini I; Gardini G; Nizzoli R; Leonardi F; Gasparro D; Camisa R; Cavalli S; Silini EM; Ardizzoni A
Br J Cancer; 2011 Apr; 104(9):1372-6. PubMed ID: 21487407
[TBL] [Abstract][Full Text] [Related]
6. Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status.
Wang T; Hsieh ET; Henry P; Hanna W; Streutker CJ; Grin A
Hum Pathol; 2014 May; 45(5):970-5. PubMed ID: 24656529
[TBL] [Abstract][Full Text] [Related]
7. Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.
Tafe LJ; Janjigian YY; Zaidinski M; Hedvat CV; Hameed MR; Tang LH; Hicks JB; Shah MA; Barbashina V
Arch Pathol Lab Med; 2011 Nov; 135(11):1460-5. PubMed ID: 22032573
[TBL] [Abstract][Full Text] [Related]
8. [Dual-color silver-enhanced in-situ hybridization for determination of HER2 gene amplification in gastric carcinoma].
Fan D; Li Y; Ran W; Yu W; Li H
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):4-7. PubMed ID: 24713241
[TBL] [Abstract][Full Text] [Related]
9. Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples.
Yan B; Yau EX; Choo SN; Ong CW; Yong KJ; Pang B; Salto-Tellez M
J Clin Pathol; 2011 Oct; 64(10):880-3. PubMed ID: 21757431
[TBL] [Abstract][Full Text] [Related]
10. Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas.
Fassan M; Ludwig K; Pizzi M; Castoro C; Guzzardo V; Balistreri M; Zaninotto G; Ruol A; Giacomelli L; Ancona E; Rugge M
Hum Pathol; 2012 Aug; 43(8):1206-12. PubMed ID: 22217477
[TBL] [Abstract][Full Text] [Related]
11. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
[TBL] [Abstract][Full Text] [Related]
12. Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes.
Kochi M; Fujii M; Masuda S; Kanamori N; Mihara Y; Funada T; Tamegai H; Watanabe M; Suda H; Takayama T
Diagn Pathol; 2013 Nov; 8():191. PubMed ID: 24261710
[TBL] [Abstract][Full Text] [Related]
13. HER2 testing in malignant effusions of metastatic gastric carcinoma: is it feasible?
Wong DD; de Boer WB; Platten MA; Jo VY; Cibas ES; Kumarasinghe MP
Diagn Cytopathol; 2015 Jan; 43(1):80-5. PubMed ID: 25363414
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections.
Lee S; de Boer WB; Fermoyle S; Platten M; Kumarasinghe MP
Histopathology; 2011 Nov; 59(5):832-40. PubMed ID: 22092394
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immunohistochemistry, four in situ hybridization methods and quantitative polymerase chain reaction for the molecular diagnosis of HER2 status in gastric cancer: a study of 55 cases.
Staněk L; Rozkoš T; Laco J; Ryška A; Petruželka L; Důra M; Dundr P
Mol Med Rep; 2014 Nov; 10(5):2669-74. PubMed ID: 25189406
[TBL] [Abstract][Full Text] [Related]
16. EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus.
Birkman EM; Ålgars A; Lintunen M; Ristamäki R; Sundström J; Carpén O
BMC Cancer; 2016 Jul; 16():406. PubMed ID: 27387915
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
Park YS; Hwang HS; Park HJ; Ryu MH; Chang HM; Yook JH; Kim BS; Jang SJ; Kang YK
Hum Pathol; 2012 Mar; 43(3):413-22. PubMed ID: 21855114
[TBL] [Abstract][Full Text] [Related]
18. HER2 Heterogeneity in Gastroesophageal Cancer Detected by Testing Biopsy and Resection Specimens.
Fazlollahi L; Remotti HE; Iuga A; Yang HM; Lagana SM; Sepulveda AR
Arch Pathol Lab Med; 2018 Apr; 142(4):516-522. PubMed ID: 28782986
[TBL] [Abstract][Full Text] [Related]
19. Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.
Gumusay O; Benekli M; Ekinci O; Baykara M; Ozet A; Coskun U; Demirci U; Uner A; Dursun A; Atak EY; Buyukberber S
Jpn J Clin Oncol; 2015 May; 45(5):416-21. PubMed ID: 25732909
[TBL] [Abstract][Full Text] [Related]
20. HER2 status in gastric cancer: a comparison of two novel in situ hybridization methods (IQ FISH and dual color SISH) and two immunohistochemistry methods (A0485 and HercepTest™).
Pala EE; Bayol U; Ozguzer A; Akman O
Pathol Res Pract; 2013 Sep; 209(9):548-54. PubMed ID: 23910175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
